Vicenza, Italy, January 27, 2015 --(PR.com
)-- The increase in sales from 2013 to 2014, the consolidation of ASAlaser’s presence in the European market for both the Human and Veterinary sectors and the opening of new markets in 2014 are the solid basis on which the company is building its 2015. This year will represent a new challenge: after the acknowledgement achieved by MLS® Laser Therapy for its effectiveness in the treatment of temporo-mandibular disorders and craniofacial pain, the dental field is in fact one of the main areas in which ASA will invest during this new season. The investment will be defined by its participation in international fairs, where the devices Mphi D and Mphi D 5, specially designed and developed by the company for the dental application of MLS®, will be presented, and by a rich international training calendar. After its presence in December along with the Thai partner to the Thailand Dental Association Congress in Bangkok, in March ASA will in fact be in Cologne with its own stand for the most important worldwide event in the dental industry. ASAlaser’s staff will also organize in the U.S., Thailand and UK some courses to explain the application of its therapeutic solutions in treating problems commonly spread in the TMD sector. These missions addressed to the "dental" field, which last year has also attracted the attention of Australia, will be put side by side with the other training sessions for professionals of veterinary medicine and physiotherapy, in order to improve their knowledge on MLS®, Hilterapia® and Magneto Therapy. The numerous missions scheduled worldwide for 2015 confirm that training represents an element of value and a distinctive tool for the company in its international development strategy.
ASA has in fact developed all its history in the sign of internationalization, since its early years. This new year will continue in the same direction: after the opening last year of new distribution channels for both the veterinary and the human fields, the company doesn’t stop and looks at new goals. "Our international position has been consolidated in recent years, thanks to the strengthening of the European market," says Lucio Zaghetto, ASAlaser CEO - It allows us to move towards new goals and take new steps. Among them, the expansion of the range of therapeutic solutions in the U.S. market through the distribution of Hilterapia®. "Thanks to MLS® we can already count on a solid presence in the U.S. market," continues Zaghetto, -"which has demonstrated over the years its receptiveness to our therapy. Now it’s time to introduce Hilterapia® that is already a consolidated therapy in other countries of the world." From the Human field to the Veterinary world there’s only a short step. If in 2014, in fact, MLS® and Mphi Vet line have successfully landed in veterinary health centers and clinics in Europe (France, England and Germany) and Oceania (Australia), thanks to new distribution partnerships, in 2015 the goal will be the consolidation of the results achieved and the opening of new markets along with those in which the company is already strongly represented: the U.S. (leader in terms of number of Mphi Vet devices installed) Sweden and Italy. ASAlaser is looking at the future, and is already working for 2016.